ACTINIUM PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $1.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-03-30
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.00K.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $10.46M.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.54M.
- 2024-01-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $373.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-14 |
| 2024-06-30 | $10.46M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $12.54M 10-Q · filed 2024-04-26 |
| 2024-01-01 | $373.00K 10-K · filed 2026-03-30 |
| 2023-12-31 | $373.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.74M 10-Q · filed 2023-11-02 |
| 2023-01-01 | $15.20M 10-K · filed 2025-03-31 |
| 2022-12-30 | $15.20M 10-Q · filed 2023-11-02 |
| 2022-09-30 | $5.38M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $92.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $120.00K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |